Show simple item record

dc.contributor.authorAljishi, M
dc.contributor.authorNasr, S
dc.contributor.authorHan, T
dc.contributor.authorThet, Z
dc.date.accessioned2021-05-14T01:44:56Z
dc.date.available2021-05-14T01:44:56Z
dc.date.issued2020
dc.identifier.issn1320-5358en_US
dc.identifier.urihttp://hdl.handle.net/10072/404383
dc.description.abstractBackground: There is a concern that biopsy risks are higher in regional Australian centres, where lack of interventional support makes management of complications difficult. Central Queensland Hospital and Health Service (CQHHS) started performing kidney biopsies in 2005 by nephrologists and then by onsite radiology from 2016 onwards. To date, no studies have evaluated epidemiology of kidney disease and safety of kidney biopsy in the Central Queensland. Aim: The aim is to determine the epidemiology of biopsy‐proven kidney disease in CQHHS and the safety of kidney biopsies. Methods: A retrospective study on native kidney biopsies in CQHHs was performed. Biopsy data from January 2005 to December 2019 was obtained from health records. Biopsies performed in CQHHS Radiology were examined for biopsy‐related complications. Results: 187 kidney biopsies occurred during the study period, of which 170 (91%) were native biopsies. The number of kidney biopsies per year has steadily increased from around 7 to 17 biopsies a year. The average age of patients undergoing biopsy was 51 years, and the average renal function was 48 mL/min/1.73 m2. The most common indications for biopsy were acute renal failure (54%), nephritic syndrome (34%), subnephrotic proteinuria (30%), and nephrotic syndrome (30%). The most common biopsy diagnoses were IgA Nephropathy (16%), diabetic nephropathy (12%), and membranous nephropathy (11%). The left kidney was targeted in 70% of biopsies and the average size was 11.3 cm. Ultrasound was used in 96% of biopsies. 10 out of 60 (17%) biopsies had a complication, predominantly minor uncomplicated haematoma while two needed intervention without any mortality. Conclusions: Kidney biopsy practice in CQHHS appears safe and provides important epidemiological data on biopsy‐proven kidney disease.en_US
dc.languageEnglishen_US
dc.publisherWileyen_US
dc.publisher.urihttps://onlinelibrary.wiley.com/doi/10.1111/nep.13799en_US
dc.relation.ispartofconferencename55th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN)en_US
dc.relation.ispartofconferencetitleNephrologyen_US
dc.relation.ispartofdatefrom2020-11-28
dc.relation.ispartofdateto2020-12-02
dc.relation.ispartoflocationVirtualen_US
dc.relation.ispartofpagefrom47en_US
dc.relation.ispartofpageto47en_US
dc.relation.ispartofissueS3en_US
dc.relation.ispartofvolume25en_US
dc.subject.fieldofresearchClinical Sciencesen_US
dc.subject.fieldofresearchcode1103en_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsLife Sciences & Biomedicineen_US
dc.subject.keywordsUrology & Nephrologyen_US
dc.titleEpidemiology and safety of kidney biopsy in central Queensland regionen_US
dc.typeConference outputen_US
dc.type.descriptionE3 - Conferences (Extract Paper)en_US
dcterms.bibliographicCitationAljishi, M; Nasr, S; Han, T; Thet, Z, Epidemiology and safety of kidney biopsy in central Queensland region, Nephrology, 2020, 25, pp. 47-47en_US
dc.date.updated2021-05-14T01:42:57Z
gro.hasfulltextNo Full Text
gro.griffith.authorThet, Zaw


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record